Title: Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach.
Journal: Toxicology and applied pharmacology 20180101
Title: IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
Journal: The Journal of biological chemistry 20171110
Title: Selective inhibition of the NLRP3 inflammasome by targeting to promyelocytic leukemia protein in mouse and human.
Journal: Blood 20130418
Title: A critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors.
Journal: PloS one 20130101
Title: Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage.
Journal: The international journal of biochemistry & cell biology 20121101
Title: Therapy with TLR7 agonists induces lymphopenia: correlating pharmacology to mechanism in a mouse model.
Journal: Journal of clinical immunology 20121001
Title: Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.
Journal: Biomaterials 20120601
Title: TLR3 but not TLR7/8 ligand induces allergic sensitization to inhaled allergen.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20120515
Title: R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts.
Journal: Cytotechnology 20120501
Title: Bacterial immunotherapy of gastrointestinal tumors.
Journal: Langenbeck's archives of surgery 20120401
Title: MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20120401
Title: Characterisation and expression analysis of the Atlantic halibut (Hippoglossus hippoglossus L.) cytokines: IL-1β, IL-6, IL-11, IL-12β and IFNγ.
Journal: Molecular biology reports 20120301
Title: R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes.
Journal: BMC infectious diseases 20120101
Title: Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development.
Journal: Journal of biomedicine & biotechnology 20120101
Title: Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.
Journal: Frontiers in physiology 20120101
Title: Uterine epithelial cells specifically induce interferon-stimulated genes in response to polyinosinic-polycytidylic acid independently of estradiol.
Journal: PloS one 20120101
Title: High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery.
Journal: PloS one 20120101
Title: Vaccine Development Against Leishmania donovani.
Journal: Frontiers in immunology 20120101
Title: Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.
Journal: Frontiers in physiology 20120101
Title: Adjuvants for Leishmania vaccines: from models to clinical application.
Journal: Frontiers in immunology 20120101
Title: Plasmacytoid dendritic cell interferon-α production to R-848 stimulation is decreased in male infants.
Journal: BMC immunology 20120101
Title: Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay.
Journal: Journal of immunological methods 20111028
Title: The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation.
Journal: Veterinary immunology and immunopathology 20111015
Title: Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110715
Title: Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms.
Journal: European journal of immunology 20110701
Title: Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4.
Journal: Arthritis and rheumatism 20110601
Title: CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
Journal: Expert review of vaccines 20110601
Title: Pattern recognition receptors and the innate immune response to viral infection.
Journal: Viruses 20110601
Title: Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells.
Journal: Blood 20110526
Title: Targeting the Toll-like receptor 7 pathway in asthma: a potential immunomodulatory approach?
Journal: Expert opinion on therapeutic targets 20110501
Title: Toll-like receptor 7/8 agonist resiquimod induces late preconditioning in neonatal cardiac myocytes.
Journal: Acta pharmacologica Sinica 20110501
Title: Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110415
Title: Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110401
Title: A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110401
Title: Stimulation of TLR7 prior to polymicrobial sepsis improves the immune control of the inflammatory response in adult mice.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20110301
Title: The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation.
Journal: PLoS pathogens 20110301
Title: Toll-like receptor 7 activation reduces the contractile response of airway smooth muscle.
Journal: European journal of pharmacology 20110210
Title: Involvement of xanthine oxidase and hypoxia-inducible factor 1 in Toll-like receptor 7/8-mediated activation of caspase 1 and interleukin-1β.
Journal: Cellular and molecular life sciences : CMLS 20110101
Title: Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.
Journal: Cancer immunology, immunotherapy : CII 20110101
Title: The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110101
Title: TLR3 and TLR7 modulate IgE production in antigen induced pulmonary inflammation via influencing IL-4 expression in immune organs.
Journal: PloS one 20110101
Title: Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.
Journal: Clinical & developmental immunology 20110101
Title: Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.
Journal: PloS one 20110101
Title: Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells.
Journal: PloS one 20110101
Title: The transcriptome of Trichuris suis--first molecular insights into a parasite with curative properties for key immune diseases of humans.
Journal: PloS one 20110101
Title: The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Journal: Cellular immunology 20110101
Title: A common path to innate immunity to HIV-1 induced by Toll-like receptor ligands in primary human macrophages.
Journal: PloS one 20110101
Title: Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission.
Journal: Journal of translational medicine 20110101
Title: Comparative analysis of species-specific ligand recognition in Toll-like receptor 8 signaling: a hypothesis.
Journal: PloS one 20110101
Title: Toll-like receptors and myocardial inflammation.
Journal: International journal of inflammation 20110101
Title: Systemic administration of CpG oligodeoxynucleotide and levamisole as adjuvants for gene-gun-delivered antitumor DNA vaccines.
Journal: Clinical & developmental immunology 20110101
Title: Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.
Journal: PloS one 20110101
Title: Signatures of positive selection in Toll-like receptor (TLR) genes in mammals.
Journal: BMC evolutionary biology 20110101
Title: The combination of early and rapid type I IFN, IL-1α, and IL-1β production are essential mediators of RNA-like adjuvant driven CD4+ Th1 responses.
Journal: PloS one 20110101
Title: Predicting antitumor activity of peptides by consensus of regression models trained on a small data sample.
Journal: International journal of molecular sciences 20110101
Title: An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles.
Journal: Clinical and vaccine immunology : CVI 20101201
Title: Exhaustive exercise reduces TNF-α and IFN-α production in response to R-848 via toll-like receptor 7 in mice.
Journal: European journal of applied physiology 20101101
Title: Inhibition of the type I interferon antiviral response during arenavirus infection.
Journal: Viruses 20101101
Title: Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100901
Title: TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity.
Journal: Vaccine 20100831
Title: 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20100701
Title: Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers.
Journal: Clinical and vaccine immunology : CVI 20100701
Title: Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.
Journal: International journal of dermatology 20100701
Title: Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
Journal: Journal of medicinal chemistry 20100408
Title: Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
Journal: Blood 20100311
Title: The role of redox-dependent mechanisms in the downregulation of ligand-induced Toll-like receptors 7, 8 and 4-mediated HIF-1 alpha prolyl hydroxylation.
Journal: Immunology and cell biology 20100201
Title: The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
Journal: Cancer immunology, immunotherapy : CII 20100101
Title: Topical resiquimod: a promising adjuvant for vaccine development?
Journal: Expert review of vaccines 20100101
Title: Toll-like receptor-mediated recognition of herpes simplex virus.
Journal: Frontiers in bioscience (Scholar edition) 20100101
Title: Molecular modulation of intestinal epithelial barrier: contribution of microbiota.
Journal: Journal of biomedicine & biotechnology 20100101
Title: Immune mechanisms of protection: can adjuvants rise to the challenge?
Journal: BMC biology 20100101
Title: Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.
Journal: PloS one 20100101
Title: Src kinases are required for a balanced production of IL-12/IL-23 in human dendritic cells activated by Toll-like receptor agonists.
Journal: PloS one 20100101
Title: Toll-like receptors: role in dermatological disease.
Journal: Mediators of inflammation 20100101
Title: Targeting Toll-like receptors for treatment of SLE.
Journal: Mediators of inflammation 20100101
Title: Cellular and molecular mechanisms underlying the strong neonatal IL-12 response of lamb mesenteric lymph node cells to R-848.
Journal: PloS one 20100101
Title: Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-κB-dependent transcription of TNF-α and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA.
Journal: Journal of inflammation (London, England) 20100101
Title: Pharmacotherapy of actinic keratosis.
Journal: Expert opinion on pharmacotherapy 20091201
Title: Topical resiquimod promotes priming of CTL to parenteral antigens.
Journal: Vaccine 20090925
Title: Modulation of the allergic asthma transcriptome following resiquimod treatment.
Journal: Physiological genomics 20090807
Title: Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20090601
Title: Do postsurgical interventions optimize ultimate scar cosmesis.
Journal: Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 20090601
Title: TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
Journal: Vaccine 20090518
Title: 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
Journal: Bioorganic & medicinal chemistry letters 20090415
Title: Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles.
Journal: Vaccine 20090414
Title: Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20090301
Title: Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term.
Journal: Biology of reproduction 20090201
Title: Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Journal: The Journal of allergy and clinical immunology 20090101
Title: Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1.
Journal: PloS one 20090101
Title: TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Journal: Immunobiology 20090101
Title: Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects.
Journal: Respiratory research 20090101
Title: Sequence determinants of innate immune activation by short interfering RNAs.
Journal: BMC immunology 20090101
Title: Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.
Journal: PloS one 20090101
Title: Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
Journal: BMC cancer 20090101
Title: Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors.
Journal: PloS one 20090101
Title: Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Journal: Journal of translational medicine 20090101
Title: Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Journal: Cancer immunology, immunotherapy : CII 20081101
Title: Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.
Journal: Experimental biology and medicine (Maywood, N.J.) 20080801
Title: A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.
Journal: The British journal of dermatology 20080701
Title: Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells.
Journal: The Journal of experimental medicine 20080609
Title: Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-gamma (IFN-gamma).
Journal: Journal of leukocyte biology 20080401
Title: Intra-colonic administration of the TLR7 agonist R-848 induces an acute local and systemic inflammation in mice.
Journal: Biochemical and biophysical research communications 20080307
Title: TLR7 and TLR8 as targets in cancer therapy.
Journal: Oncogene 20080107
Title: Comparison of human B cell activation by TLR7 and TLR9 agonists.
Journal: BMC immunology 20080101
Title: Toll-like receptors and viruses: induction of innate antiviral immune responses.
Journal: The open microbiology journal 20080101
Title: Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase.
Journal: The Journal of biological chemistry 20071221
Title: TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response.
Journal: European journal of immunology 20071001
Title: Resiquimod and other immune response modifiers as vaccine adjuvants.
Journal: Expert review of vaccines 20071001
Title: Impaired CCR7 expression on plasmacytoid dendritic cells of HIV-infected children and adolescents with immunologic and virologic failure.
Journal: Journal of acquired immune deficiency syndromes (1999) 20070815
Title: Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies.
Journal: Journal of hepatology 20070801
Title: The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20070501
Title: Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Journal: The Journal of infectious diseases 20070501
Title: Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20070401
Title: Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects.
Journal: Journal of molecular biology 20070105
Title: TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation.
Journal: Journal of leukocyte biology 20070101
Title: Therapeutic use of Aldara in chronic myeloid leukemia.
Journal: Journal of translational medicine 20070101
Title: Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.
Journal: Journal of translational medicine 20070101
Title: Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
Journal: Journal of translational medicine 20070101
Title: Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
Journal: Journal of translational medicine 20070101
Title: Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists.
Journal: BMC immunology 20070101
Title: HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.
Journal: PloS one 20070101
Title: Primary prevention of allergic diseases: current concepts and mechanisms.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20070101
Title: Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20061201
Title: A distinct subset of intestinal dendritic cells responds selectively to oral TLR7/8 stimulation.
Journal: European journal of immunology 20061001
Title: Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling.
Journal: The Journal of biological chemistry 20060915
Title: Toll-like receptor priming sensitizes macrophages to proinflammatory cytokine gene induction by deoxynivalenol and other toxicants.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20060801
Title: Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages.
Journal: FEMS immunology and medical microbiology 20060801
Title: Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Journal: European journal of immunology 20060701
Title: Toll-like receptors mediate proliferation and survival of multiple myeloma cells.
Journal: Leukemia 20060601
Title: [Application of imiquimod and resiquimod in dermatology].
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20060601
Title: TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway.
Journal: American journal of physiology. Lung cellular and molecular physiology 20060501
Title: Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20060501
Title: Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers.
Journal: Journal of medicinal chemistry 20060323
Title: Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.
Journal: Nature 20060309
Title: Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848).
Journal: Antiviral research 20060201
Title: New approaches to vaccine adjuvants: inhibiting the inhibitor.
Journal: PLoS medicine 20060101
Title: The role of topical immune response modifiers in skin cancer.
Journal: Drugs 20060101
Title: Innate immunity for biodefense: a strategy whose time has come.
Journal: The Journal of allergy and clinical immunology 20051201
Title: TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).
Journal: Vaccine 20051101
Title: TLR and NOD2 ligands induce cell proliferation in the rat intact spinal cord.
Journal: Journal of neuropathology and experimental neurology 20051101
Title: Microglia activation in rat spinal cord by systemic injection of TLR3 and TLR7/8 agonists.
Journal: Journal of neuroimmunology 20050701
Title: A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Journal: The Journal of experimental medicine 20050502
Title: Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20050401
Title: Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens.
Journal: Immunology 20050401
Title: Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Journal: Immunology 20050401
Title: Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20050201
Title: Toll-like receptor downstream signaling.
Journal: Arthritis research & therapy 20050101
Title: Generation and maturation of dendritic cells for clinical application under serum-free conditions.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20050101
Title: Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses.
Journal: Antiviral research 20041101
Title: Emerging therapies for herpes viral infections (types 1 - 8).
Journal: Expert opinion on emerging drugs 20041101
Title: Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20041001
Title: Topical immunomodulation in dermatology: potential of toll-like receptor agonists.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20040801
Title: Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20040801
Title: Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20040615
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040601
Title: Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.
Journal: The Journal of investigative dermatology 20040501
Title: Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod.
Journal: Apoptosis : an international journal on programmed cell death 20040501
Title: Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
Journal: Vaccine 20040416
Title: Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.
Journal: Vaccine 20040416
Title: Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20040415
Title: The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.
Journal: European journal of immunology 20031101
Title: Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures.
Journal: The British journal of dermatology 20031101
Title: Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20031015
Title: Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.
Journal: Journal of the National Cancer Institute 20030806
Title: An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Journal: The American journal of pathology 20030801
Title: [Topical immunomodulators in dermatology].
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030701
Title: The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.
Journal: The Journal of allergy and clinical immunology 20030201
Title: Resiquimod 3M.
Journal: Current opinion in investigational drugs (London, England : 2000) 20030201
Title: Recurrent genital herpes treatments and their impact on quality of life.
Journal: PharmacoEconomics 20030101
Title: [Imiquimod and resiquimod. The onset of a new pharmaco-therapeutic class?].
Journal: Annales de dermatologie et de venereologie 20030101
Title: Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors.
Journal: The Journal of investigative dermatology 20021101
Title: Current treatments and perceptions of genital herpes: a European-wide view.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20021101
Title: Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.
Journal: Nature immunology 20020601
Title: The clinical management of recurrent genital herpes: current issues and future prospects.
Journal: Herpes : the journal of the IHMF 20020401
Title: Herpes simplex viruses 1 and 2.
Journal: Dermatologic clinics 20020401
Title: Immunomodulation as a treatment strategy for genital herpes: review of the evidence.
Journal: International immunopharmacology 20020301
Title: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
Journal: Nature immunology 20020201
Title: Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Journal: Cellular immunology 20020101
Title: Imiquimod and resiquimod as novel immunomodulators.
Journal: The Journal of antimicrobial chemotherapy 20011201
Title: Topical immunomodulators--progress towards treating inflammation, infection, and cancer.
Journal: The Lancet. Infectious diseases 20011001
Title: Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study.
Journal: The Journal of infectious diseases 20010715
Title: Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment.
Journal: The Journal of infectious diseases 20010315
Title: The immune response modifier resiquimod mimics CD40-induced B cell activation.
Journal: Cellular immunology 20010225
Title: Immunomodulating and antiviral activities of the imidazoquinoline S-28463.
Journal: Antiviral research 19951101
Title: Editorials: More health care with less.
Journal: Dimensions in health service 19751201
Title: Sachan S, et al. Adjuvant potential of resiquimod with inactivated Newcastle disease vaccine and its mechanism of action in chicken. Vaccine. 2015 Aug 26;33(36):4526-32.
Title: Brugnolo F, et al. The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. J Allergy Clin Immunol. 2003 Feb;111(2):380-8.
Title: Zhou ZX, et al. Immune effects of R848: evidences that suggest an essential role of TLR7/8-induced, Myd88- and NF-κB-dependent signaling in the antiviral immunity of Japanese flounder (Paralichthys olivaceus). Dev Comp Immunol. 2015 Mar;49(1):113-20.
